Clin2
NCT06940908Possibly a fitRecruiting

Living with Guillain-Barré syndrome as a child

Guillain Barré SyndromeGuillain-Barré Syndrome (GBS)

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
25 people
Ages
10 years to 18 years
Study type
Observational

Who can take part

  • You were diagnosed with Guillain-Barré syndrome as a child
  • You are at least 10 years old now
  • Your GBS episode happened between 2 and 5 years ago
  • You can speak French well enough for a conversation
  • You are willing to give consent (or your parent can give consent if you are under 18)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07842705Not yet recruiting
Heart changes in children with Guillain-Barré syndrome

This study looks at how Guillain-Barré syndrome, a condition that causes muscle weakness, might affect the heart in children. It aims to find out if there are heart problems that need extra care.

NCT04829526Recruiting
Study of suspected Guillain-Barré syndrome cases

This is an observational study that looks at people who were suspected to have Guillain-Barré syndrome and were cared for at University Hospital of Basel in the past. It does not test a new treatment—researchers review existing care to learn more about this condition.

Basel
NCT05461898Recruiting
Rehabilitation program for adults with Guillain-Barré syndrome

This trial studies whether an inpatient rehabilitation program can help people with Guillain-Barré syndrome. It may be useful if you need structured therapy and support during recovery.

Vila Nova de Gaia
NCT06885762Not yet recruiting· Phase 2/Phase 3
Efgartigimod for treating Guillain-Barré syndrome

This trial tests a new medicine called efgartigimod for people with Guillain-Barré syndrome (GBS), a condition where the immune system attacks the nerves. The medicine aims to reduce the immune attack and help you recover faster. It is for people who started having GBS symptoms within the last 2 weeks and have moderate to severe symptoms.

NCT07806916Not yet recruiting· Phase 2
Efgartigimod for recent Guillain-Barré syndrome

This trial tests whether an experimental drug called efgartigimod (given as an infusion) can help people with Guillain-Barré syndrome recover faster. It is for adults who recently developed symptoms and have significant weakness that affects their walking.

NCT07866898Not yet recruiting
Ultrasound of arm and leg nerves in children with Guillain-Barré syndrome

This study uses ultrasound to look at the nerves in children with Guillain-Barré syndrome, a condition that causes weakness. It aims to see if ultrasound can help doctors understand or monitor the disease.

Hear when a new Guillain Barré Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.